Protalix BioTherapeutics (PLX) Non Operating Income (2012 - 2026)

Protalix BioTherapeutics' (PLX) quarterly Non Operating Income came in at -$5000.0 in Q1 2026, down 101.21% year-on-year from $413000.0 in Q1 2025, and up 95.76% quarter-over-quarter from -$118000.0 in Q4 2025.

Protalix BioTherapeutics (PLX) Non Operating Income (2012 - 2026) Analysis & Trends

Protalix BioTherapeutics' Non Operating Income history runs 15 years deep, the most recent figure standing at -$5000.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 101.21% year-over-year to -$5000.0 in Q1 2026; TTM through Mar 2026 was -$526000.0, a 199.81% decrease from a year earlier, with the FY2025 full-year figure at -$108000.0, down 145.57% from the prior year.
  • Non Operating Income climbed to -$5000.0 in Q1 2026 per PLX's latest filing, from -$118000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $413000.0 in Q1 2025 and bottomed at -$811000.0 in Q4 2023.
  • The 5-year median for Non Operating Income is -$118000.0 (2025), against an average of -$185470.6.
  • Across the five-year window, Non Operating Income plunged 507.37% in 2023 and surged 235.77% in 2025, its largest moves.
  • Year by year, Non Operating Income stood at -$715000.0 in 2022, then declined by 13.43% to -$811000.0 in 2023, then soared by 113.19% to $107000.0 in 2024, then tumbled by 210.28% to -$118000.0 in 2025, then soared by 95.76% to -$5000.0 in 2026.
  • Per Business Quant, the three latest PLX Non Operating Income figures stand at -$5000.0 (Q1 2026), -$118000.0 (Q4 2025), and $108000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Protalix BioTherapeutics 190.95 Mn 180.16 Mn 29.62 Mn -5,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,000.00
Dec 31, 2025 -118,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 -511,000.00
Mar 31, 2025 413,000.00
Dec 31, 2024 107,000.00
Sep 30, 2024 -148,000.00
Jun 30, 2024 155,000.00
Mar 31, 2024 123,000.00
Dec 31, 2023 -811,000.00
Sep 30, 2023 168,000.00
Jun 30, 2023 -774,000.00
Mar 31, 2023 -477,000.00
Dec 31, 2022 -715,000.00
Sep 30, 2022 -442,000.00
Jun 30, 2022 190,000.00
Mar 31, 2022 -416,000.00
Dec 31, 2021 -910,000.00
Sep 30, 2021 -2.31 Mn
Jun 30, 2021 -2.08 Mn